{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T14:27:03Z","timestamp":1783607223006,"version":"3.55.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T00:00:00Z","timestamp":1611792000000},"content-version":"am","delay-in-days":362,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["NEWTBVAC n\u00b0241745"],"award-info":[{"award-number":["NEWTBVAC n\u00b0241745"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["TBVAC2020 n\u00b0643381"],"award-info":[{"award-number":["TBVAC2020 n\u00b0643381"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Universit\u00e9 Paul Sabatier"},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-11-EQUIPEX-0003"],"award-info":[{"award-number":["ANR-11-EQUIPEX-0003"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["DEQ2016 0334902"],"award-info":[{"award-number":["DEQ2016 0334902"]}],"id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.vaccine.2019.11.085","type":"journal-article","created":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T21:34:26Z","timestamp":1576618466000},"page":"1416-1423","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Preclinical assessment of a new live attenuated Mycobacterium tuberculosis Beijing-based vaccine for tuberculosis"],"prefix":"10.1016","volume":"38","author":[{"given":"Florence","family":"Levillain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kee","family":"Woong Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Cia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wladimir","family":"Malaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faye","family":"Lanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscille","family":"Brodin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Gicquel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Guilhot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory J.","family":"Bancroft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung","family":"Jae Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannick","family":"Poquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Neyrolles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.11.085_b0005","series-title":"Global tuberculosis report 2018","year":"2018"},{"key":"10.1016\/j.vaccine.2019.11.085_b0010","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/S0140-6736(19)30308-3","article-title":"Tuberculosis","volume":"393","author":"Furin","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2019.11.085_b0015","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.smim.2018.06.002","article-title":"Non-specific effects of vaccines: current evidence and potential implications","volume":"39","author":"de Bree","year":"2018","journal-title":"Semin Immunol"},{"key":"10.1016\/j.vaccine.2019.11.085_b0020","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/infdis\/jiw228","article-title":"Vaccination against tuberculosis with whole-cell mycobacterial vaccines","volume":"214","author":"Scriba","year":"2016","journal-title":"J Infect Dis"},{"issue":"1\u2013372","key":"10.1016\/j.vaccine.2019.11.085_b0025","first-page":"v","article-title":"Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette-Guerin vaccination against tuberculosis","volume":"17","author":"Abubakar","year":"2013","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.vaccine.2019.11.085_b0030","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1001\/jama.291.17.2086","article-title":"Long-term efficacy of BCG vaccine in American Indians and Alaska Natives: A 60-year follow-up study","volume":"291","author":"Aronson","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2019.11.085_b0035","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1473-3099(15)00400-4","article-title":"Duration of BCG protection against tuberculosis and change in effectiveness with time since vaccination in Norway: a retrospective population-based cohort study","volume":"16","author":"Nguipdop-Djomo","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2019.11.085_b0040","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/s41577-019-0174-z","article-title":"Moving tuberculosis vaccines from theory to practice","volume":"19","author":"Andersen","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2019.11.085_b0045","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(95)92348-9","article-title":"Variation in protection by BCG: implications of and for heterologous immunity","volume":"346","author":"Fine","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2019.11.085_b0050","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0140-6736(96)02166-6","article-title":"repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Karonga Prevention Trial Group","volume":"348","author":"Randomised controlled trial of single BCG","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2019.11.085_b0055","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S0140-6736(05)67145-0","article-title":"Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial","volume":"366","author":"Rodrigues","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2019.11.085_b0060","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1016\/j.vaccine.2011.05.023","article-title":"Evidence of an effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: second report of the BCG-REVAC cluster-randomised trial","volume":"29","author":"Barreto","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.11.085_b0065","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1016\/j.vaccine.2014.05.042","article-title":"Causes of variation in BCG vaccine efficacy: examining evidence from the BCG REVAC cluster randomized trial to explore the masking and the blocking hypotheses","volume":"32","author":"Barreto","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.11.085_b0070","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMoa1714021","article-title":"Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination","volume":"379","author":"Nemes","year":"2018","journal-title":"New England J Med"},{"key":"10.1016\/j.vaccine.2019.11.085_b0075","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1016\/j.vaccine.2009.12.083","article-title":"The second Geneva Consensus: recommendations for novel live TB vaccines","volume":"28","author":"Walker","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.11.085_b0080","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.3389\/fimmu.2017.01203","article-title":"TBVAC2020: advancing tuberculosis vaccines from discovery to clinical development","volume":"8","author":"Kaufmann","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2019.11.085_b0085","doi-asserted-by":"crossref","first-page":"199","DOI":"10.12688\/f1000research.13588.1","article-title":"Progress and challenges in TB vaccine development","volume":"7","author":"Voss","year":"2018","journal-title":"F1000 Res"},{"key":"10.1016\/j.vaccine.2019.11.085_b0090","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.vaccine.2012.12.053","article-title":"Safety and immunogenicity of the recombinant BCG vaccine VPM1002 in a phase 1 open-label randomized clinical trial","volume":"31","author":"Grode","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.11.085_b0095","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1172\/JCI24617","article-title":"Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guerin mutants that secrete listeriolysin","volume":"115","author":"Grode","year":"2005","journal-title":"J Clin Investig"},{"key":"10.1016\/j.vaccine.2019.11.085_b0100","doi-asserted-by":"crossref","DOI":"10.1128\/CVI.00439-16","article-title":"Safety and immunogenicity of the recombinant mycobacterium bovis BCG vaccine VPM1002 in HIV-unexposed newborn infants in South Africa","volume":"24","author":"Loxton","year":"2017","journal-title":"Clin Vaccine Immunol: CVI"},{"key":"10.1016\/j.vaccine.2019.11.085_b0105","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.3389\/fimmu.2017.01147","article-title":"The Recombinant bacille calmette-guerin vaccine VPM1002: ready for clinical efficacy testing","volume":"8","author":"Nieuwenhuizen","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2019.11.085_b0110","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1016\/j.vaccine.2013.07.051","article-title":"Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials","volume":"31","author":"Arbues","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.11.085_b0115","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1016\/j.vaccine.2006.03.017","article-title":"The live Mycobacterium tuberculosis phoP mutant strain is more attenuated than BCG and confers protective immunity against tuberculosis in mice and guinea pigs","volume":"24","author":"Martin","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.11.085_b0120","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S2213-2600(15)00435-X","article-title":"Safety of human immunisation with a live-attenuated Mycobacterium tuberculosis vaccine: a randomised, double-blind, controlled phase I trial","volume":"3","author":"Spertini","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.vaccine.2019.11.085_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(19)30251-6","article-title":"Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trial","author":"Tameris","year":"2019","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.vaccine.2019.11.085_b0130","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/infdis\/jix030","article-title":"Revaccination of guinea pigs with the live attenuated mycobacterium tuberculosis vaccine MTBVAC improves BCG's protection against tuberculosis","volume":"216","author":"Clark","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.11.085_b0135","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nrmicro.2018.8","article-title":"Ecology and evolution of Mycobacterium tuberculosis","volume":"16","author":"Gagneux","year":"2018","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2019.11.085_b0140","first-page":"4","article-title":"Impact of genetic diversity on the biology of mycobacterium tuberculosis complex strains","author":"Niemann","year":"2016","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.vaccine.2019.11.085_b0145","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.mib.2017.11.021","article-title":"Evolution of virulence in the Mycobacterium tuberculosis complex","volume":"41","author":"Orgeur","year":"2018","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.vaccine.2019.11.085_b0150","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/ng.3195","article-title":"Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage","volume":"47","author":"Merker","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.vaccine.2019.11.085_b0155","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S1473-3099(09)70330-5","article-title":"Possible underlying mechanisms for successful emergence of the Mycobacterium tuberculosis Beijing genotype strains","volume":"10","author":"Parwati","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2019.11.085_b0160","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1046\/j.1365-2249.2003.02171.x","article-title":"A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes","volume":"133","author":"Lopez","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2019.11.085_b0165","doi-asserted-by":"crossref","first-page":"5126","DOI":"10.1016\/j.vaccine.2006.11.024","article-title":"BCG vaccination confers poor protection against M. tuberculosis HN878-induced central nervous system disease","volume":"25","author":"Tsenova","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.11.085_b0170","doi-asserted-by":"crossref","first-page":"e0136500","DOI":"10.1371\/journal.pone.0136500","article-title":"The efficacy of the BCG vaccine against newly emerging clinical strains of mycobacterium tuberculosis","volume":"10","author":"Henao-Tamayo","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.11.085_b0175","doi-asserted-by":"crossref","first-page":"5173","DOI":"10.1128\/IAI.00019-08","article-title":"Mycobacterium bovis BCG immunization induces protective immunity against nine different Mycobacterium tuberculosis strains in mice","volume":"76","author":"Jeon","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.11.085_b0180","doi-asserted-by":"crossref","first-page":"e1001100","DOI":"10.1371\/journal.ppat.1001100","article-title":"High content phenotypic cell-based visual screen identifies Mycobacterium tuberculosis acyltrehalose-containing glycolipids involved in phagosome remodeling","volume":"6","author":"Brodin","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2019.11.085_b0185","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1046\/j.1365-2958.2001.02500.x","article-title":"An essential role for phoP in Mycobacterium tuberculosis virulence","volume":"41","author":"Perez","year":"2001","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2019.11.085_b0190","doi-asserted-by":"crossref","first-page":"11491","DOI":"10.1073\/pnas.1406693111","article-title":"Evolutionary history of tuberculosis shaped by conserved mutations in the PhoPR virulence regulator","volume":"111","author":"Gonzalo-Asensio","year":"2014","journal-title":"Proceedings National Acad Sci USA"},{"key":"10.1016\/j.vaccine.2019.11.085_b0195","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1099\/00221287-148-10-3007","article-title":"Specialized transduction: an efficient method for generating marked and unmarked targeted gene disruptions in Mycobacterium tuberculosis, M. bovis BCG and M. smegmatis","volume":"148","author":"Bardarov","year":"2002","journal-title":"Microbiology"},{"key":"10.1016\/j.vaccine.2019.11.085_b0200","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1016\/j.vaccine.2015.03.083","article-title":"Increased protective efficacy of recombinant BCG strains expressing virulence-neutral proteins of the ESX-1 secretion system","volume":"33","author":"Bottai","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.11.085_b0205","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.tube.2010.12.007","article-title":"Deciphering the role of IS6110 in a highly transmissible Mycobacterium tuberculosis Beijing strain, GC1237","volume":"91","author":"Alonso","year":"2011","journal-title":"Tuberculosis"},{"key":"10.1016\/j.vaccine.2019.11.085_b0210","doi-asserted-by":"crossref","first-page":"e3496","DOI":"10.1371\/journal.pone.0003496","article-title":"PhoP: a missing piece in the intricate puzzle of Mycobacterium tuberculosis virulence","volume":"3","author":"Gonzalo-Asensio","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.11.085_b0215","doi-asserted-by":"crossref","first-page":"16085","DOI":"10.1038\/ncomms16085","article-title":"Reactogenicity to major tuberculosis antigens absent in BCG is linked to improved protection against Mycobacterium tuberculosis","volume":"8","author":"Aguilo","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2019.11.085_b0220","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1016\/j.celrep.2017.02.057","article-title":"Recombinant BCG Expressing ESX-1 of Mycobacterium marinum Combines Low Virulence with Cytosolic Immune Signaling and Improved TB Protection","volume":"18","author":"Groschel","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.vaccine.2019.11.085_b0225","doi-asserted-by":"crossref","first-page":"5752","DOI":"10.1073\/pnas.091096998","article-title":"Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha \/beta","volume":"98","author":"Manca","year":"2001","journal-title":"Proceedings National Acad Sci USA"},{"key":"10.1016\/j.vaccine.2019.11.085_b0230","doi-asserted-by":"crossref","DOI":"10.1128\/JB.00696-16","article-title":"Unique Regulation of the DosR Regulon in the Beijing Lineage of Mycobacterium tuberculosis","volume":"199","author":"Domenech","year":"2017","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2019.11.085_b0235","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1128\/JB.01597-09","article-title":"Strains of the East Asian (W\/Beijing) lineage of Mycobacterium tuberculosis are DosS\/DosT-DosR two-component regulatory system natural mutants","volume":"192","author":"Fallow","year":"2010","journal-title":"J Bacteriol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19316391?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19316391?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:38:45Z","timestamp":1759401525000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19316391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0264410X19316391"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.11.085","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical assessment of a new live attenuated Mycobacterium tuberculosis Beijing-based vaccine for tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.11.085","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}